Center for Computational Health, IBM Research, 75 Binney Street, Cambridge, MA, 02142, USA.
Atrius Health, Boston, MA, USA.
Sci Rep. 2021 Jan 13;11(1):1139. doi: 10.1038/s41598-021-80967-5.
To support point-of-care decision making by presenting outcomes of past treatment choices for cohorts of similar patients based on observational data from electronic health records (EHRs), a machine-learning precision cohort treatment option (PCTO) workflow consisting of (1) data extraction, (2) similarity model training, (3) precision cohort identification, and (4) treatment options analysis was developed. The similarity model is used to dynamically create a cohort of similar patients, to inform clinical decisions about an individual patient. The workflow was implemented using EHR data from a large health care provider for three different highly prevalent chronic diseases: hypertension (HTN), type 2 diabetes mellitus (T2DM), and hyperlipidemia (HL). A retrospective analysis demonstrated that treatment options with better outcomes were available for a majority of cases (75%, 74%, 85% for HTN, T2DM, HL, respectively). The models for HTN and T2DM were deployed in a pilot study with primary care physicians using it during clinic visits. A novel data-analytic workflow was developed to create patient-similarity models that dynamically generate personalized treatment insights at the point-of-care. By leveraging both knowledge-driven treatment guidelines and data-driven EHR data, physicians can incorporate real-world evidence in their medical decision-making process when considering treatment options for individual patients.
为了通过基于电子健康记录 (EHR) 的观察数据为相似患者群体展示过去治疗选择的结果来支持即时决策,开发了一种机器学习精准队列治疗选项 (PCTO) 工作流程,包括 (1) 数据提取、(2) 相似性模型训练、(3) 精准队列识别和 (4) 治疗选项分析。相似性模型用于动态创建相似患者群体,为个体患者的临床决策提供信息。该工作流程使用来自大型医疗保健提供商的 EHR 数据在三个不同的常见慢性病(高血压 (HTN)、2 型糖尿病 (T2DM) 和高脂血症 (HL))中实施。回顾性分析表明,大多数情况下都有更好的治疗选择(HTN、T2DM、HL 的比例分别为 75%、74%、85%)。HTN 和 T2DM 的模型已在初级保健医生的试点研究中部署,并在就诊期间使用。开发了一种新颖的数据分析工作流程,以创建患者相似性模型,在即时护理点动态生成个性化的治疗见解。通过利用知识驱动的治疗指南和数据驱动的 EHR 数据,医生可以在考虑个体患者的治疗选择时将真实世界的证据纳入他们的医疗决策过程中。